Rigel Pharmaceuticals reported $13.3M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Amgen USD 6.39B 169M Sep/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.93B 362M Jun/2026
BioMarin Pharmaceutical USD 1.8B 13.54M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Daiichi Sankyo JPY 733.05B 40.68B Jun/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Halozyme Therapeutics USD 132.61M 4.52M Sep/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 14.51M 4.24M Sep/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Neurocrine Biosciences USD 66.1M 38.1M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Ultragenyx Pharmaceutical USD 59M 0 Sep/2026
Veracyte USD 25.82M 3.16M Sep/2026